Alnylam Pharmaceuticals, Inc. (ALNY)
291.56
+5.29
(+1.85%)
USD |
NASDAQ |
May 19, 13:54
Alnylam Pharmaceuticals EPS Diluted (TTM) : 4.209 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | -0.4552 |
| Ionis Pharmaceuticals, Inc. | -2.102 |
| Gilead Sciences, Inc. | 7.349 |
| Regeneron Pharmaceuticals, Inc. | 41.04 |
| Sarepta Therapeutics, Inc. | -0.9641 |